v3 Template
N

NeuroTherapia

Biotechnology / Healthcare ~20 employees
Founded
--
Employees (Est.)
~20
2 leaders known
Total Funding
$12.3M
Funding Rounds
1
Last Funding
2024-08-06

About NeuroTherapia

NeuroTherapia, Inc. is a company focused on developing small molecule therapies to treat central nervous system (CNS) diseases, particularly by addressing neuroinflammation. Their approach targets microglia cells to reduce inflammation in the CNS, offering a novel therapeutic strategy that could complement existing antibody therapies.

Products & Services

NTRX-07:An orally available small molecule therapy that reduces inflammation and enhances the brain's ability to form new connections, improving learning and memory. It is in development for CNS conditions, with Phase 1b clinical trial data showing a favorable safety profile and a trend toward cognitive improvement in Alzheimer's disease patients.

Specialties

Neuroinflammation treatment Central Nervous System (CNS) diseases Small molecule therapeutics Microglia cell inhibition Alzheimer's disease treatment

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series B
T: -
FT: Series B 		A: 12300000
MR: -
FA: 12.3M
FAN: 12300000 		D: 2024-08-06
FD: 2024-08-06 		6 investors
Series B Latest
2024-08-06
$12.3M
6 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

T

Tony Giordano

President & CEO

LinkedIn (Pro only)
J

Joseph Foss

Founder & Chief Medical Officer

LinkedIn (Pro only)

Recent News

NeuroTherapia Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Healthcare
Company Size
~20 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro